Cherk Martin H, Patil Sushrut, Beech Paul, Kalff Victor
Department of Nuclear Medicine, The Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia.
J Med Case Rep. 2014 Nov 7;8:362. doi: 10.1186/1752-1947-8-362.
The use of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) scanning for baseline staging and assessment of treatment response for higher grade lymphomas is considered to be the standard of care. Evaluation of lymphomatous bone marrow infiltration on 18F-FDG PET can usually distinguish between normal regenerating marrow following chemotherapy by a characteristic pattern of uptake.
Here we report the case of a 51-year-old Caucasian woman with mixed low- and high-grade lymphoma with biopsy confirmed marrow infiltration. An interim post-three cycle chemotherapy 18F-FDG PET scan revealed apparent progression of marrow disease. Subsequent investigations were performed including bone marrow biopsies, repeat 18F-FDG PET scanning and a white cell scan. These revealed the interim 18F-FDG PET scan appearance was due to a highly unusual pattern of scattered islands of regenerating normal marrow, rather than progressive lymphoma.
Our case report highlights that apparent severe bone marrow abnormalities on 18F-FDG PET scans in lymphoma patients treated with chemotherapy are not always due to disease. Clinicians should retain a high index of suspicion for benign causes when 18F-FDG PET scan results appear incongruent with clinical response.
使用18F-氟脱氧葡萄糖正电子发射断层扫描(18F-FDG PET)对高级别淋巴瘤进行基线分期和治疗反应评估被认为是标准治疗方法。通过特征性的摄取模式,18F-FDG PET对淋巴瘤骨髓浸润的评估通常能够区分化疗后正常再生的骨髓。
我们在此报告一名51岁白种女性,患有低级别和高级别混合性淋巴瘤,活检证实有骨髓浸润。化疗三个周期后的18F-FDG PET中期扫描显示骨髓疾病明显进展。随后进行了包括骨髓活检、重复18F-FDG PET扫描和白细胞扫描在内的检查。这些检查显示,中期18F-FDG PET扫描表现是由于再生正常骨髓散在岛状分布的一种非常不寻常的模式,而非淋巴瘤进展。
我们的病例报告强调,接受化疗的淋巴瘤患者18F-FDG PET扫描中明显的严重骨髓异常并不总是由疾病引起。当18F-FDG PET扫描结果与临床反应不一致时,临床医生应高度怀疑良性病因。